CD44 and cancer: The expression intensity of CD44 on circulating MDSCs was also dim suggesting more immature phenotype (Figure 8), however, the percentage of CD44+MDSCs (irrespective of the CD44 marker intensity) was higher in the blood of mice with advanced cancer (Figure 9).